BOSTON SCIENTIFIC CORPORATION Deferred Income Tax Assets, Net
BOSTON SCIENTIFIC CORPORATION (BSX) had Deferred Income Tax Assets, Net of $3.91 billion as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DeferredIncomeTaxAssetsNet · last filed 2026-08-03
- 2026-06-30: Deferred Income Tax Assets, Net $3.91B.
- 2026-03-31: Deferred Income Tax Assets, Net $3.95B.
- 2025-12-31: Deferred Income Tax Assets, Net $3.67B.
- 2025-09-30: Deferred Income Tax Assets, Net $3.67B.
| Period end | Deferred Income Tax Assets, Net |
|---|---|
| 2026-06-30 | $3.91B 10-Q · filed 2026-08-03 |
| 2026-03-31 | $3.95B 10-Q · filed 2026-05-01 |
| 2025-12-31 | $3.67B 10-Q · filed 2026-08-03 |
| 2025-09-30 | $3.67B 10-Q · filed 2025-11-03 |
| 2025-06-30 | $3.78B 10-Q · filed 2025-08-01 |
| 2025-03-31 | $3.68B 10-Q · filed 2025-05-01 |
| 2024-12-31 | $3.65B 10-K · filed 2026-02-17 |
| 2024-09-30 | $3.82B 10-Q · filed 2024-11-01 |
| 2024-06-30 | $3.80B 10-Q · filed 2024-08-01 |
| 2024-03-31 | $3.79B 10-Q · filed 2024-05-01 |
| 2023-12-31 | $3.84B 10-K · filed 2025-02-18 |
| 2023-09-30 | $3.84B 10-Q · filed 2023-11-01 |
| 2023-06-30 | $3.87B 10-Q · filed 2023-08-03 |
| 2023-03-31 | $3.90B 10-Q · filed 2023-05-04 |
| 2022-12-31 | $3.94B 10-K · filed 2024-02-20 |
| 2022-09-30 | $4.02B 10-Q · filed 2022-11-03 |
| 2022-06-30 | $4.06B 10-Q · filed 2022-08-04 |
| 2022-03-31 | $4.10B 10-Q · filed 2022-05-05 |
| 2021-12-31 | $4.14B 10-K · filed 2023-02-23 |
| 2021-09-30 | $4.05B 10-Q · filed 2021-11-04 |
| 2021-06-30 | $4.04B 10-Q · filed 2021-08-06 |
| 2021-03-31 | $4.17B 10-Q · filed 2021-05-06 |
| 2020-12-31 | $4.21B 10-K · filed 2022-02-23 |
| 2020-09-30 | $4.17B 10-Q · filed 2020-11-05 |
| 2020-06-30 | $4.18B 10-Q · filed 2020-08-05 |
| 2020-03-31 | $4.16B 10-Q · filed 2020-05-06 |
| 2019-12-31 | $4.20B 10-K · filed 2021-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |